Stay updated on RC48-ADC in Low HER2 Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T20:22:00.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a minor software update with no visible changes to study content.
    Difference
    0.0%
    Check dated 2026-03-07T05:56:53.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2. The study details page content remains unchanged.
    Difference
    0.0%
    Check dated 2026-02-13T13:37:33.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Version bump from v3.4.0 to v3.4.1. No visible changes to the study details page.
    Difference
    0.0%
    Check dated 2026-02-06T09:14:21.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4. No substantive study information appears to be modified.
    Difference
    0.0%
    Check dated 2026-01-15T05:00:54.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    The page now includes an administrative update showing the last known status with sponsor RemeGen Co., Ltd.; date 2023-12; verification status 'Verified'; and 'Unknown status'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-12-31T23:50:09.000Z thumbnail image

Stay in the know with updates to RC48-ADC in Low HER2 Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.